KLRK1 and neoplasm: Given that NKG2D can be chronically upregulated under immune stress or aging conditions (e.g., due to persistent ligand engagement or DNA damage responses) [40], its normalization following JTT may reflect a balanced immunomodulatory effect, preventing overactivation and functional exhaustion of NK cells within the tumor-related immune environment.